Ronald Louis Docie

The Inventor's Bible, Fourth Edition (eBook, ePUB)

How to Market and License Your Brilliant Ideas

• Format: ePub

Produktbeschreibung

The definitive guide for inventors, newly updated with the latest patenting laws, information on crowdfunding, and online resources. The path to success is clearer than it's ever been! Thanks to experienced inventor Ronald Docie, the process of commercializing your invention and receiving royalties is no longer complicated. The Inventor's Bible is an in-depth how-to manual for both beginners and skilled entrepreneurs alike that helps you develop a realistic, workable plan, research your market, target potential business partners, and strike a good deal for your inventions. It tackles vital concerns, such as: What is my invention worth? What steps should I take first? Is free government help available? Who can I trust, and how can I keep from getting ripped off? Revised to reflect recent changes and innovations, this fourth edition includes: • Crowdfunding and Crowdsourcing • Open Innovation • Free Patenting Help • New U.S. Patent Laws • America Invents Act • Freedom to Use Law • Online Help for Inventors With The Inventor's Bible, your dream can become the world's next great invention.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Clarkson Potter/Ten Speed
• Seitenzahl: 376
• Erscheinungstermin: 1. September 2015
• Englisch
• ISBN-13: 9781607749288
• Artikelnr.: 43700929

Autorenporträt

RONALD LOUIS DOCIE's career in the world of inventions spans almost four decades. His own inventions are found in Wal-Mart, Kmart, and thousands of other outlets. As the president of Docie Development, LLC, an international company that provides services for inventors and corporations, Docie has negotiated over fifty licenses with such companies as General Motors. He is an expert consultant on idea submission to Johnson & Johnson and other prominent companies.